Do variants in PPARG, MC4R, LEPR, LEP, and ADIPOQ influence obstructive sleep apnea susceptibility?

Genetic variants in metabolic regulation genes—including PPARG, MC4R, LEPR, LEP, and ADIPOQ—significantly influence susceptibility to obstructive sleep apnea (OSA) through a combination of structural, metabolic, and neurological mechanisms.

Adiposity and insulin sensitivity pathways

• PPARG and ADIPOQ dynamics: The PPARG rs1801282 (Pro12Ala) polymorphism and variants in ADIPOQ are established regulators of adiposity, body mass index (BMI), fat distribution, and insulin sensitivity. Altered insulin sensitivity, independent of BMI, modifies sleep architecture and metabolic syndrome phenotypes associated with sleep disordered breathing.
• Bidirectional causality: Mendelian randomization and genetic correlation analyses demonstrate a strong, bidirectional causal relationship between adiposity and OSA, showing that genetic susceptibility to elevated BMI drives physical airway compromise, while OSA concurrently exacerbates adiposity.

Central signaling and neuromuscular mechanisms

• The leptin-melanocortin axis: Genetic alterations in LEP, LEPR, and MC4R impair appetite signaling, driving hyperphagia and metabolic dysfunction.
• Ventilatory and airway control: Beyond weight gain, leptin and melanocortin-4 receptors help govern central ventilatory and respiratory control. Dysregulated adipokine signaling (including leptin and adiponectin) is mechanistically linked to systemic inflammation and impaired upper airway neuromuscular control, though separating these central effects from general BMI-associated mechanical airway collapse remains a major clinical challenge.

Bottom line

• Genetic variation in PPARG, MC4R, LEPR, LEP, and ADIPOQ influences OSA susceptibility primarily through physical airway compromise driven by adiposity and altered insulin sensitivity, with emerging but complex secondary contributions from central ventilatory control and inflammatory adipokine pathways.